Skip to main content

Table 3 Prevalence of RTOG grade 2 or higher genitourinary or gastrointestinal toxicity

From: Favorable outcomes in locally advanced and node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy

  RTOG Grade 2 toxicity RTOG Grade 3 toxicity
GU-tract, N (%)   
 Hematuria 2 (1) 1 (<1)
 Urinary retention 6 (4) 2 (1)
 Urinary frequency 49 (36) 14 (10)
 Dysuria 5 (4) 2 (1)
 Urinary urgency 63 (46) 15 (11)
 Urinary leakage 5 (4) 1 (<1)
GI-tract, N (%)   
 Fecal urgency 37 (27) 2 (1)
 Blood in stool 17 (13) 0 (0)
 Loose stools 10 (7) 1 (<1)
 Fecal incontinence 10 (7) 1 (<1)
  1. Abbreviations: Genitourinary (GU), Gastrointestinal (GI)